Vaxcell-Bio Therapeutics Co., Ltd. Stock: price and insider trades · South Korea
박셀바이오
No insider purchase over the last 90 days. The latest, by 이제중, was filed 27 Mar 2026.
Who traded when
BuySaleSince the insiders bought
- -51.5%Entry ₩7,810 · Close 29 Oct 2026 ₩3,790
- -51.5%Entry ₩7,810 · Close 29 Oct 2026 ₩3,790
- -27.3%Entry ₩12,770 · Close at T+365 ₩9,290
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
- 1,000 shares@ ₩7,800.000.0074% mcap100.0% of flowShareKRXDART:20260327001034Canonical exit: 23 Jun 2026 (T+90)
- 1,000 shares@ ₩7,870.000.0074% mcap100.0% of flowShareKRXDART:20260327001038Canonical exit: 23 Jun 2026 (T+90)
- ●Executives0DART
- 4,551 sharesKRXDART:20260108000623Canonical exit: 2 Apr 2026 (T+90)
- 1,118 sharesShareKRXDART:20260108000616Canonical exit: 8 Apr 2026 (T+90)
- 400 sharesShareKRXDART:20260108000614Canonical exit: 8 Apr 2026 (T+90)
- 1,928 sharesShareKRXDART:20260108000617Canonical exit: 8 Apr 2026 (T+90)
- ●Executives0DART
- 268,029 sharesKRXDART:20250205000456
- 2,015,877 sharesKRXDART:20241025000512Canonical exit: 16 Jan 2025 (T+90)
- 150,000 sharesShareKRXDART:20241025000452
- 2,244,921 sharesKRXDART:20241025000445
- 637,961 sharesKRXDART:20240531002827
- ShareKRXDART:20240521000235Canonical exit: 18 Aug 2024 (T+90)
- 2,015,877 sharesKRXDART:20240521000219Canonical exit: 31 Jul 2024 (T+90)
- 2,015,877 sharesKRXDART:20240513000016Canonical exit: 31 Jul 2024 (T+90)
- 2,015,877 sharesKRXDART:20240510001055Canonical exit: 31 Jul 2024 (T+90)
- 1,000 shares@ ₩16,440.0071.4% of flowShareKRXDART:20240502000457Canonical exit: 25 Jul 2024 (T+90)
- ShareKRXDART:20231213000375
- ShareKRXDART:20231213000387
- 2,015,877 sharesKRXDART:20231117000117Canonical exit: 8 Feb 2024 (T+90)
- ShareKRXDART:20231116000202
- ShareKRXDART:20231116000210
- ShareKRXDART:20231116000216
- 2,015,877 sharesKRXDART:20231031000505Canonical exit: 23 Jan 2024 (T+90)
25 of 38 declarations
About Vaxcell-Bio Therapeutics Co., Ltd.
At Vaxcell-Bio Therapeutics Co., Ltd. (박셀바이오), a Korean health care company on the Korea Exchange valued at KRW 97.1 billion, insiders and declared holders own only 12.3% of the capital. The record holds 19 purchases and 5 sales on the market (79% purchases), three of the purchases with an amount, EUR 20,157 in all with a median of EUR 4,517.
The largest, EUR 11,163, is 정성창's (부사장, vice president) on April 26, 2024; next come EUR 4,517 by 이제중 (대표이사) and EUR 4,477 by 정성창, both on March 25, 2026. 이제중 has 19 filings, including 3 purchases and 4 sales; 이준행 has 12, with 11 purchases and one sale. From January 2, 2026 to January 8, 2026, 4 filers bought.
Read moreShow less
The 38 filings were published from April 5, 2021 to March 27, 2026: 16 in 2023, 9 in 2024, 7 in 2026 and only 2 each in 2021, 2022 and 2025. Over twelve months: 7 filings, 6 purchases and no sale. Filings appear a median of 7 days after the trade, over 25 measurements.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
